Prospective validation of the prognostic and predictive impact of uPA/PAI-1 in early breast cancer. [PDF]
Wieder V +16 more
europepmc +1 more source
Beyond Direct Fibrinolysis: Novel Approaches to Thrombolysis. [PDF]
Shibeko AM +4 more
europepmc +1 more source
Soluble urokinase plasminogen activator receptor and perioperative complications: a systematic review. [PDF]
Gungor AB +4 more
europepmc +1 more source
Pro-Coagulant Lipids in Physiological Ratios Found in the Activated Platelet Membrane Do Not Impact Clot Structure or Fibrinolysis in Purified Assays. [PDF]
Morgan BH +8 more
europepmc +2 more sources
The role of suPAR and related proteins in kidney, heart diseases, and diabetes. [PDF]
Reiser J, Hayek SS, Sever S.
europepmc +1 more source
Plasminogen activator urokinase receptor (PLAUR; uPAR; suPAR) [PDF]
openaire +1 more source
Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival. [PDF]
Hisada Y, Mackman N.
europepmc +1 more source
Plasminogen activator urokinase receptor (PLAUR; uPAR; suPAR) [PDF]
openaire +1 more source
The Role of Extracellular Proteases and Extracellular Matrix Remodeling in the Pre-Metastatic Niche. [PDF]
Okura GC, Bharadwaj AG, Waisman DM.
europepmc +1 more source
Soluble urokinase Plasminogen Activator Receptor in Critical Illness
Soluble urokinase Plasminogen Activator Receptor (suPAR) on seerumista, plasmasta, aivo-selkäydinnesteestä, amnionnesteestä tai muista elimistön nestetiloista mitattava biomarkkeri, jonka tutkimusnäyttö on osoittanut olevan useissa sairaustiloissa ja myös väestötasolla ennusteellinen.
openaire +2 more sources

